These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34007331)

  • 1. Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma.
    Liu W; Xia Y; Li M; Abulajiang G; Wang H; Su L; Li C; Shi Y; Zhang W; Xu S; Ma Y
    Exp Ther Med; 2021 Jul; 22(1):722. PubMed ID: 34007331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells.
    Zhang K; Fang T; Shao Y; Wu Y
    Cancer Manag Res; 2021; 13():7087-7099. PubMed ID: 34531686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
    Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
    Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.
    Qin Y; Zhao W; Cheng L; Wu S; Wu Q; Gao J; Bian Z; Ma L
    Int J Clin Exp Pathol; 2019; 12(7):2462-2473. PubMed ID: 31934073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
    Wang HR; Wang MH; Lian GY; Wu DG
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
    Wang H; Wang M; Lian G; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma.
    Yang H; Xu L; Qian H; Niu X; Zhao D; Zhao Z; Wu J; Liu J; Wang Y
    Mol Med Rep; 2016 May; 13(5):4143-50. PubMed ID: 27035126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
    Liu J; Xia J; Zhang Y; Fu M; Gong S; Guo Y
    Oncol Lett; 2017 Sep; 14(3):3275-3281. PubMed ID: 28927077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
    Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
    Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the correlativity of gender determining region Y-box 4, N-cadherin, CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma.
    Qin Y; Zhao W; Cheng L; Gao J; Bian Z; Wu S; Cheng Z; Tao Y; Ma L
    Int J Clin Exp Pathol; 2019; 12(5):1745-1756. PubMed ID: 31933993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma.
    Song L; Wang Z; Liu X
    Thorac Cardiovasc Surg; 2013 Sep; 61(6):479-85. PubMed ID: 22547301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
    Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
    Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin.
    Weng W; Yin J; Zhang Y; Qiu J; Wang X
    Int J Oncol; 2014 Mar; 44(3):812-8. PubMed ID: 24424621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.
    Niu G; Zhuang H; Li B; Cao G
    J BUON; 2018; 23(1):157-162. PubMed ID: 29552776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
    Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
    Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.